{"id":"https://openalex.org/W2043946207","doi":"https://doi.org/10.1182/blood-2004-03-1110","title":"From the bench to the bedside: ways to improve rituximab efficacy","display_name":"From the bench to the bedside: ways to improve rituximab efficacy","publication_year":2004,"publication_date":"2004-06-30","ids":{"openalex":"https://openalex.org/W2043946207","doi":"https://doi.org/10.1182/blood-2004-03-1110","mag":"2043946207","pmid":"https://pubmed.ncbi.nlm.nih.gov/15226177"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2004-03-1110","doi":"https://doi.org/10.1182/blood-2004-03-1110","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2004-03-1110","pdf_url":"https://ashpublications.org/blood/article-pdf/104/9/2635/1702949/zh802104002635.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2043946207"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://ashpublications.org/blood/article-pdf/104/9/2635/1702949/zh802104002635.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031977714","display_name":"Guillaume Cartron","orcid":"https://orcid.org/0000-0003-0659-9635","observed_orcids":["https://orcid.org/0000-0003-0659-9635"]},"institutions":[{"id":"https://openalex.org/I110017253","display_name":"Universit\u00e9 de Tours","ror":"https://ror.org/02wwzvj46","country_code":"FR","type":"education","lineage":["https://openalex.org/I110017253"]},{"id":"https://openalex.org/I4210095477","display_name":"Centre Hospitalier Universitaire de Tours","ror":"https://ror.org/00jpq0w62","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210095477"]},{"id":"https://openalex.org/I4210123491","display_name":"Centre Jean Bernard","ror":"https://ror.org/02s2qzh96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210123491"]},{"id":"https://openalex.org/I4210139676","display_name":"Canc\u00e9rop\u00f4le Grand Ouest","ror":"https://ror.org/03vx94b97","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210139676"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Guillaume Cartron","raw_affiliation_strings":["From the UPRES-EA Immuno-Pharmaco-Ge\u0301ne\u0301tique des Anticorps the\u0301rapeutiques (IPGA), UPRES-EA, Universite\u0301 Franc\u0327ois Rabelais, Tours, France; Oncologie Me\u0301dicale et Maladies du Sang; Laboratoire d'Immunologie, Centre Hospitalier Universitaire de Tours, France Laboratory of Cellular and Gene Therapy \u201cG Lanzani,\u201d Ospedali Riuniti Bergamo, Italia; Centre Jean Bernard, Le Mans, France; and Cance\u0301ropo\u0302le Grand Ouest, France","Centre Jean Bernard, Le Mans, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the UPRES-EA Immuno-Pharmaco-Ge\u0301ne\u0301tique des Anticorps the\u0301rapeutiques (IPGA), UPRES-EA, Universite\u0301 Franc\u0327ois Rabelais, Tours, France; Oncologie Me\u0301dicale et Maladies du Sang; Laboratoire d'Immunologie, Centre Hospitalier Universitaire de Tours, France Laboratory of Cellular and Gene Therapy \u201cG Lanzani,\u201d Ospedali Riuniti Bergamo, Italia; Centre Jean Bernard, Le Mans, France; and Cance\u0301ropo\u0302le Grand Ouest, France","institution_ids":["https://openalex.org/I110017253","https://openalex.org/I4210095477","https://openalex.org/I4210123491","https://openalex.org/I4210139676"]},{"raw_affiliation_string":"Centre Jean Bernard, Le Mans, France","institution_ids":["https://openalex.org/I4210123491"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011831250","display_name":"Herv\u00e9 Watier","orcid":"https://orcid.org/0000-0002-2139-4171","observed_orcids":["https://orcid.org/0000-0002-2139-4171"]},"institutions":[{"id":"https://openalex.org/I110017253","display_name":"Universit\u00e9 de Tours","ror":"https://ror.org/02wwzvj46","country_code":"FR","type":"education","lineage":["https://openalex.org/I110017253"]},{"id":"https://openalex.org/I4210095477","display_name":"Centre Hospitalier Universitaire de Tours","ror":"https://ror.org/00jpq0w62","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210095477"]},{"id":"https://openalex.org/I4210123491","display_name":"Centre Jean Bernard","ror":"https://ror.org/02s2qzh96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210123491"]},{"id":"https://openalex.org/I4210139676","display_name":"Canc\u00e9rop\u00f4le Grand Ouest","ror":"https://ror.org/03vx94b97","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210139676"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Herve\u0301 Watier","raw_affiliation_strings":["From the UPRES-EA Immuno-Pharmaco-Ge\u0301ne\u0301tique des Anticorps the\u0301rapeutiques (IPGA), UPRES-EA, Universite\u0301 Franc\u0327ois Rabelais, Tours, France; Oncologie Me\u0301dicale et Maladies du Sang; Laboratoire d'Immunologie, Centre Hospitalier Universitaire de Tours, France Laboratory of Cellular and Gene Therapy \u201cG Lanzani,\u201d Ospedali Riuniti Bergamo, Italia; Centre Jean Bernard, Le Mans, France; and Cance\u0301ropo\u0302le Grand Ouest, France","Centre Jean Bernard, Le Mans, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the UPRES-EA Immuno-Pharmaco-Ge\u0301ne\u0301tique des Anticorps the\u0301rapeutiques (IPGA), UPRES-EA, Universite\u0301 Franc\u0327ois Rabelais, Tours, France; Oncologie Me\u0301dicale et Maladies du Sang; Laboratoire d'Immunologie, Centre Hospitalier Universitaire de Tours, France Laboratory of Cellular and Gene Therapy \u201cG Lanzani,\u201d Ospedali Riuniti Bergamo, Italia; Centre Jean Bernard, Le Mans, France; and Cance\u0301ropo\u0302le Grand Ouest, France","institution_ids":["https://openalex.org/I110017253","https://openalex.org/I4210095477","https://openalex.org/I4210123491","https://openalex.org/I4210139676"]},{"raw_affiliation_string":"Centre Jean Bernard, Le Mans, France","institution_ids":["https://openalex.org/I4210123491"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018208681","display_name":"Jos\u00e9e Golay","orcid":"https://orcid.org/0000-0002-7932-909X","observed_orcids":["https://orcid.org/0000-0002-7932-909X"]},"institutions":[{"id":"https://openalex.org/I110017253","display_name":"Universit\u00e9 de Tours","ror":"https://ror.org/02wwzvj46","country_code":"FR","type":"education","lineage":["https://openalex.org/I110017253"]},{"id":"https://openalex.org/I4210095477","display_name":"Centre Hospitalier Universitaire de Tours","ror":"https://ror.org/00jpq0w62","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210095477"]},{"id":"https://openalex.org/I4210123491","display_name":"Centre Jean Bernard","ror":"https://ror.org/02s2qzh96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210123491"]},{"id":"https://openalex.org/I4210139676","display_name":"Canc\u00e9rop\u00f4le Grand Ouest","ror":"https://ror.org/03vx94b97","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210139676"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jose\u0301e Golay","raw_affiliation_strings":["From the UPRES-EA Immuno-Pharmaco-Ge\u0301ne\u0301tique des Anticorps the\u0301rapeutiques (IPGA), UPRES-EA, Universite\u0301 Franc\u0327ois Rabelais, Tours, France; Oncologie Me\u0301dicale et Maladies du Sang; Laboratoire d'Immunologie, Centre Hospitalier Universitaire de Tours, France Laboratory of Cellular and Gene Therapy \u201cG Lanzani,\u201d Ospedali Riuniti Bergamo, Italia; Centre Jean Bernard, Le Mans, France; and Cance\u0301ropo\u0302le Grand Ouest, France","Centre Jean Bernard, Le Mans, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the UPRES-EA Immuno-Pharmaco-Ge\u0301ne\u0301tique des Anticorps the\u0301rapeutiques (IPGA), UPRES-EA, Universite\u0301 Franc\u0327ois Rabelais, Tours, France; Oncologie Me\u0301dicale et Maladies du Sang; Laboratoire d'Immunologie, Centre Hospitalier Universitaire de Tours, France Laboratory of Cellular and Gene Therapy \u201cG Lanzani,\u201d Ospedali Riuniti Bergamo, Italia; Centre Jean Bernard, Le Mans, France; and Cance\u0301ropo\u0302le Grand Ouest, France","institution_ids":["https://openalex.org/I110017253","https://openalex.org/I4210095477","https://openalex.org/I4210123491","https://openalex.org/I4210139676"]},{"raw_affiliation_string":"Centre Jean Bernard, Le Mans, France","institution_ids":["https://openalex.org/I4210123491"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108629887","display_name":"Philippe Solal\u2010C\u00e9ligny","orcid":"https://orcid.org/0000-0002-3953-972X","observed_orcids":["https://orcid.org/0000-0002-3953-972X"]},"institutions":[{"id":"https://openalex.org/I110017253","display_name":"Universit\u00e9 de Tours","ror":"https://ror.org/02wwzvj46","country_code":"FR","type":"education","lineage":["https://openalex.org/I110017253"]},{"id":"https://openalex.org/I4210095477","display_name":"Centre Hospitalier Universitaire de Tours","ror":"https://ror.org/00jpq0w62","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210095477"]},{"id":"https://openalex.org/I4210123491","display_name":"Centre Jean Bernard","ror":"https://ror.org/02s2qzh96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210123491"]},{"id":"https://openalex.org/I4210139676","display_name":"Canc\u00e9rop\u00f4le Grand Ouest","ror":"https://ror.org/03vx94b97","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210139676"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Solal-Celigny","raw_affiliation_strings":["From the UPRES-EA Immuno-Pharmaco-Ge\u0301ne\u0301tique des Anticorps the\u0301rapeutiques (IPGA), UPRES-EA, Universite\u0301 Franc\u0327ois Rabelais, Tours, France; Oncologie Me\u0301dicale et Maladies du Sang; Laboratoire d'Immunologie, Centre Hospitalier Universitaire de Tours, France Laboratory of Cellular and Gene Therapy \u201cG Lanzani,\u201d Ospedali Riuniti Bergamo, Italia; Centre Jean Bernard, Le Mans, France; and Cance\u0301ropo\u0302le Grand Ouest, France","Centre Jean Bernard, Le Mans, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the UPRES-EA Immuno-Pharmaco-Ge\u0301ne\u0301tique des Anticorps the\u0301rapeutiques (IPGA), UPRES-EA, Universite\u0301 Franc\u0327ois Rabelais, Tours, France; Oncologie Me\u0301dicale et Maladies du Sang; Laboratoire d'Immunologie, Centre Hospitalier Universitaire de Tours, France Laboratory of Cellular and Gene Therapy \u201cG Lanzani,\u201d Ospedali Riuniti Bergamo, Italia; Centre Jean Bernard, Le Mans, France; and Cance\u0301ropo\u0302le Grand Ouest, France","institution_ids":["https://openalex.org/I110017253","https://openalex.org/I4210095477","https://openalex.org/I4210123491","https://openalex.org/I4210139676"]},{"raw_affiliation_string":"Centre Jean Bernard, Le Mans, France","institution_ids":["https://openalex.org/I4210123491"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":{"value":5500,"currency":"USD","value_usd":5500},"fwci":7.3045,"has_fulltext":true,"cited_by_count":537,"citation_normalized_percentile":{"value":0.99519231,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"104","issue":"9","first_page":"2635","last_page":"2642"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":1.0},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.8970000147819519},{"id":"https://openalex.org/keywords/b-cell-non-hodgkin-lymphoma","display_name":"B-cell non-Hodgkin lymphoma","score":0.9800000190734863},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.9729999899864197},{"id":"https://openalex.org/keywords/aggressive-lymphoma","display_name":"aggressive lymphoma","score":0.6830000281333923},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.8479999899864197},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6710000038146973},{"id":"https://openalex.org/keywords/complement-mediated-cell-lysis","display_name":"complement-mediated lysis","score":0.9390000104904175},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9980000257492065},{"id":"https://openalex.org/keywords/monoclonal-antibody-therapy","display_name":"monoclonal antibody therapy","score":0.8740000128746033}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.9611161947250366},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.6925873756408691},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6871629357337952},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.6689203381538391},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6261186003684998},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.622412919998169},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6032233238220215},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5304056406021118},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.48901423811912537},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4651191234588623},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44070854783058167},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18252170085906982},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017452","descriptor_name":"Receptors, IgG","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017452","descriptor_name":"Receptors, IgG","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1182/blood-2004-03-1110","doi":"https://doi.org/10.1182/blood-2004-03-1110","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2004-03-1110","pdf_url":"https://ashpublications.org/blood/article-pdf/104/9/2635/1702949/zh802104002635.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:15226177","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15226177","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1182/blood-2004-03-1110","doi":"https://doi.org/10.1182/blood-2004-03-1110","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2004-03-1110","pdf_url":"https://ashpublications.org/blood/article-pdf/104/9/2635/1702949/zh802104002635.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2043946207.pdf","grobid_xml":"https://content.openalex.org/works/W2043946207.grobid-xml"},"referenced_works_count":98,"referenced_works":["https://openalex.org/W27919971","https://openalex.org/W33733012","https://openalex.org/W60759546","https://openalex.org/W76624571","https://openalex.org/W78060682","https://openalex.org/W147398146","https://openalex.org/W1490815823","https://openalex.org/W1511416976","https://openalex.org/W1518819083","https://openalex.org/W1522731616","https://openalex.org/W1524901905","https://openalex.org/W1529809181","https://openalex.org/W1573856597","https://openalex.org/W1589026573","https://openalex.org/W1599883407","https://openalex.org/W1600440610","https://openalex.org/W1659193542","https://openalex.org/W1682849199","https://openalex.org/W1685882185","https://openalex.org/W1809924897","https://openalex.org/W1854005499","https://openalex.org/W1890466892","https://openalex.org/W1893837372","https://openalex.org/W1898469614","https://openalex.org/W1913007537","https://openalex.org/W1915689252","https://openalex.org/W1965962344","https://openalex.org/W1966279605","https://openalex.org/W1972073735","https://openalex.org/W1976835009","https://openalex.org/W1977206110","https://openalex.org/W1979336667","https://openalex.org/W1984829276","https://openalex.org/W1985005581","https://openalex.org/W1985460392","https://openalex.org/W1991360369","https://openalex.org/W1997208169","https://openalex.org/W1997236192","https://openalex.org/W1999954189","https://openalex.org/W2004635475","https://openalex.org/W2007436659","https://openalex.org/W2009219530","https://openalex.org/W2010614363","https://openalex.org/W2011319944","https://openalex.org/W2022623654","https://openalex.org/W2027374210","https://openalex.org/W2032454178","https://openalex.org/W2033485934","https://openalex.org/W2035277855","https://openalex.org/W2038539216","https://openalex.org/W2040426470","https://openalex.org/W2044360617","https://openalex.org/W2050243165","https://openalex.org/W2057796652","https://openalex.org/W2059347528","https://openalex.org/W2059949924","https://openalex.org/W2062118343","https://openalex.org/W2063792914","https://openalex.org/W2063840206","https://openalex.org/W2065316818","https://openalex.org/W2065900855","https://openalex.org/W2066485964","https://openalex.org/W2069524809","https://openalex.org/W2077778400","https://openalex.org/W2079756029","https://openalex.org/W2081717004","https://openalex.org/W2084136419","https://openalex.org/W2096055205","https://openalex.org/W2101720268","https://openalex.org/W2104334201","https://openalex.org/W2104940816","https://openalex.org/W2108350814","https://openalex.org/W2109502548","https://openalex.org/W2112212243","https://openalex.org/W2115351802","https://openalex.org/W2117486036","https://openalex.org/W2125212191","https://openalex.org/W2128402413","https://openalex.org/W2130901389","https://openalex.org/W2133190090","https://openalex.org/W2138916760","https://openalex.org/W2139276446","https://openalex.org/W2148766690","https://openalex.org/W2150679053","https://openalex.org/W2152810214","https://openalex.org/W2153230421","https://openalex.org/W2161122282","https://openalex.org/W2168508518","https://openalex.org/W2168648203","https://openalex.org/W2168750246","https://openalex.org/W2169740898","https://openalex.org/W2170938637","https://openalex.org/W2264636885","https://openalex.org/W2339091398","https://openalex.org/W2343168847","https://openalex.org/W2343271354","https://openalex.org/W2411489146","https://openalex.org/W2791218690"],"related_works":["https://openalex.org/W2072922980","https://openalex.org/W1983522573","https://openalex.org/W1991234643","https://openalex.org/W2035277855","https://openalex.org/W2088332148","https://openalex.org/W2133205391","https://openalex.org/W2162305597","https://openalex.org/W2125693489","https://openalex.org/W1997629499","https://openalex.org/W93991088"],"abstract_inverted_index":{"Rituximab":[0,23,58,85],"(MabThera,":[1],"Rituxan)":[2],"is":[3,24],"a":[4,88,95],"chimeric":[5],"IgG1":[6],"monoclonal":[7],"antibody":[8],"that":[9,115],"specifically":[10],"targets":[11],"the":[12,28,102,106],"CD20":[13],"surface":[14],"antigen":[15],"expressed":[16],"on":[17],"normal":[18],"and":[19,33,51,67,73,112,137],"neoplastic":[20],"B-lymphoid":[21],"cells.":[22],"currently":[25],"used":[26],"in":[27,44,71,83,128],"treatment":[29],"of":[30,47,56,80,105,108,110,124],"both":[31],"follicular":[32],"aggressive":[34],"B-cell":[35],"non-Hodgkin":[36],"lymphomas.":[37],"Despite":[38],"its":[39,43,118],"demonstrated":[40],"clinical":[41,119],"effectiveness,":[42],"vivo":[45,129],"mechanisms":[46,82],"action":[48,109],"remain":[49],"unknown":[50],"could":[52,116],"differ":[53],"by":[54],"subtype":[55],"lymphoma.":[57],"has":[59,87],"been":[60],"shown":[61],"to":[62,134],"induce":[63],"apoptosis,":[64],"complement-mediated":[65],"lysis,":[66],"antibody-dependent":[68],"cellular":[69],"cytotoxicity":[70],"vitro,":[72],"some":[74],"evidence":[75],"points":[76],"toward":[77],"an":[78],"involvement":[79],"these":[81],"vivo.":[84],"also":[86],"delayed":[89],"therapeutic":[90,140],"effect":[91],"as":[92,94],"well":[93],"potential":[96],"\"vaccinal\"":[97],"effect.":[98],"Here,":[99],"we":[100],"review":[101],"current":[103],"understanding":[104,123],"mechanism":[107],"rituximab":[111,126],"discuss":[113],"approaches":[114],"increase":[117],"activity.":[120],"A":[121],"better":[122],"how":[125],"acts":[127],"should":[130],"make":[131],"it":[132],"possible":[133],"develop":[135],"new":[136],"more":[138],"effective":[139],"strategies.":[141]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":17},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":20},{"year":2015,"cited_by_count":30},{"year":2014,"cited_by_count":30},{"year":2013,"cited_by_count":25},{"year":2012,"cited_by_count":32}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}